The talent study

Research output: Contribution to journalArticle

Abstract

Current guidelines on antihypertensive treatment emphasize the importance of combination drug treatment for achieving a full blood pressure control. The TALENT Study, involving more than 400 high-risk hypertensive patients, aimed to evaluate the efficacy and safety profile of nifedipine gastrointestinal therapeutic system (GITS) 20 mg/telmisartan 80 mg combination, as compared to the single monotherapies. After 8 weeks, ambulatory blood pressure values were significantly more reduced by the combination treatment than by single monotherapies. These potentiated blood-pressure-lowering effects were mirrored by a higher trough-to-peak ratio and smoothness index. They were also accompanied by: i) significantly greater blood pressure (particularly systolic) control; ii) a greater ability of combination drug treatment to achieve a controlled blood pressure at a time earlier than that found in single monotherapies; and iii) a better side-effects profile.

Original languageEnglish
Pages (from-to)607-611
Number of pages5
JournalExpert Opinion on Pharmacotherapy
Volume13
Issue number4
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Aptitude
Blood Pressure
Drug Combinations
Therapeutics
Nifedipine
Antihypertensive Agents
Guidelines
Safety

Keywords

  • Ambulatory blood pressure
  • Blood pressure control
  • Combination drug treatment
  • Hypertension
  • Monotherapy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

The talent study. / Grassi, Guido.

In: Expert Opinion on Pharmacotherapy, Vol. 13, No. 4, 03.2012, p. 607-611.

Research output: Contribution to journalArticle

Grassi, Guido. / The talent study. In: Expert Opinion on Pharmacotherapy. 2012 ; Vol. 13, No. 4. pp. 607-611.
@article{08bf4b3e94754d24958238a0203b5474,
title = "The talent study",
abstract = "Current guidelines on antihypertensive treatment emphasize the importance of combination drug treatment for achieving a full blood pressure control. The TALENT Study, involving more than 400 high-risk hypertensive patients, aimed to evaluate the efficacy and safety profile of nifedipine gastrointestinal therapeutic system (GITS) 20 mg/telmisartan 80 mg combination, as compared to the single monotherapies. After 8 weeks, ambulatory blood pressure values were significantly more reduced by the combination treatment than by single monotherapies. These potentiated blood-pressure-lowering effects were mirrored by a higher trough-to-peak ratio and smoothness index. They were also accompanied by: i) significantly greater blood pressure (particularly systolic) control; ii) a greater ability of combination drug treatment to achieve a controlled blood pressure at a time earlier than that found in single monotherapies; and iii) a better side-effects profile.",
keywords = "Ambulatory blood pressure, Blood pressure control, Combination drug treatment, Hypertension, Monotherapy",
author = "Guido Grassi",
year = "2012",
month = "3",
doi = "10.1517/14656566.2012.658772",
language = "English",
volume = "13",
pages = "607--611",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - The talent study

AU - Grassi, Guido

PY - 2012/3

Y1 - 2012/3

N2 - Current guidelines on antihypertensive treatment emphasize the importance of combination drug treatment for achieving a full blood pressure control. The TALENT Study, involving more than 400 high-risk hypertensive patients, aimed to evaluate the efficacy and safety profile of nifedipine gastrointestinal therapeutic system (GITS) 20 mg/telmisartan 80 mg combination, as compared to the single monotherapies. After 8 weeks, ambulatory blood pressure values were significantly more reduced by the combination treatment than by single monotherapies. These potentiated blood-pressure-lowering effects were mirrored by a higher trough-to-peak ratio and smoothness index. They were also accompanied by: i) significantly greater blood pressure (particularly systolic) control; ii) a greater ability of combination drug treatment to achieve a controlled blood pressure at a time earlier than that found in single monotherapies; and iii) a better side-effects profile.

AB - Current guidelines on antihypertensive treatment emphasize the importance of combination drug treatment for achieving a full blood pressure control. The TALENT Study, involving more than 400 high-risk hypertensive patients, aimed to evaluate the efficacy and safety profile of nifedipine gastrointestinal therapeutic system (GITS) 20 mg/telmisartan 80 mg combination, as compared to the single monotherapies. After 8 weeks, ambulatory blood pressure values were significantly more reduced by the combination treatment than by single monotherapies. These potentiated blood-pressure-lowering effects were mirrored by a higher trough-to-peak ratio and smoothness index. They were also accompanied by: i) significantly greater blood pressure (particularly systolic) control; ii) a greater ability of combination drug treatment to achieve a controlled blood pressure at a time earlier than that found in single monotherapies; and iii) a better side-effects profile.

KW - Ambulatory blood pressure

KW - Blood pressure control

KW - Combination drug treatment

KW - Hypertension

KW - Monotherapy

UR - http://www.scopus.com/inward/record.url?scp=84857325203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857325203&partnerID=8YFLogxK

U2 - 10.1517/14656566.2012.658772

DO - 10.1517/14656566.2012.658772

M3 - Article

C2 - 22332938

AN - SCOPUS:84857325203

VL - 13

SP - 607

EP - 611

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 4

ER -